Insiders Buy the Dip From Stockholm to Hong Kong
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The most striking pattern in recently disclosed insider filings is concentrated buying across three continents, with sellers concentrated in a single corner of biotech.
Li Ning's Controlling Shareholder Goes All In
The biggest single story is Li Ning on the Hong Kong exchange. Viva China Holdings, the investment vehicle controlled by sportswear founder Li Ning himself, filed a series of open-market purchases in late August and early September. The total across six separate days of buying comes to roughly $160m. That is not a passive rebalancing. It is a controlling shareholder spending at scale while the stock was under pressure.
Three Boards Back Dick's at $129
DICK'S Sporting Goods attracted three separate board members buying in the same week. Director Mark Barrenechea filed a $2.2m purchase at $130.72. Vice Chairman William Colombo added two tranches totalling around $785,000. A third director also bought. All filings were reported on 28 August. The stock carries short interest of 18.3% of free float, among the highest in US retail. That cluster of board conviction against a heavy short position is worth watching.
argenx CEO Sells $21m at the Top
argenx founder and CEO Timothy Van Hauwermeiren filed the sale of 20,000 shares at $908 each, totalling $21.1m, with the filing dated 5 September. The CMO and General Counsel also sold in the same two-week window. Three C-suite sellers in quick succession is a pattern, even at a $57bn company where short interest is negligible at just 1.1% of free float.
Industrivarden Loads Up on Essity
Swedish investment company Industrivarden, which holds a board seat at Essity B, bought roughly $18.4m worth of shares in a single session on 24 August. Activist fund Cevian Capital also disclosed a $34.9m purchase, though that trade was dated July and filed later. Two large shareholders adding on the same name in the same reporting window signals coordinated confidence in the hygiene group's recovery story.
Stocks in this article
How this article was generated
- Generated
- 6 Nov 2026, 12:13
- Prompt version
- v1.0
- Data sources
- Institutional positioningAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.